Close Menu

HIV

Although the collaboration is aimed at increasing physician knowledge of genomic testing associated with all HIV drugs, it appears to have stemmed from lower-than-expected sales of Pfizer's CCR5-antagonist Selzentry.

The funds will support development of a high-throughput platform for screening infectious disease treatments.

The FDA approved an additional intended use for Roche's licensed Cobas TaqScreen MPX nucleic acid test to screen donated source plasma.

According to ViiV CEO Dominique Limet, the new company’s unique structure has the potential to “re-energize” the pharmaceutical industry’s involvement in driving HIV treatment innovation and improving access.

Genetic benefit management company Generation Health will assist the nation’s largest pharmacy services provider, CVS Caremark, to extend pharmacogenomics testing services to its pharmacy benefit management customers.

A new study suggests reversed-transcribed HIV-1 viruses that aren't integrated into the human genome have a chromatin structure and are transcriptionally silenced by epigenetic modifications.

The company said it is working with the City of Hope to investigate the vector-based delivery of an anti-HIV RNA cocktail composed of pHIV7, an shRNA targeting an exon in HIV-1 tat/rev, and a Tar decoy.

Last week's ruling "is a complete victory for Roche," an attorney for the company told GenomeWeb Daily News.

The agreement covers systems for HIV and hepatitis B management.

In an interview with Pharmacogenomics Reporter this week, Hakan Sakul provided a snapshot of Pfizer's efforts in personalized medicine, the company's stance on regulatory issues, and its overall focus on "omics"-guided medicine.

Pages

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.